Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Cellular Microbiology|September 13, 2005
Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificityTohru Yamada, Arsenio M Fialho, Vasu Punj, et al.Antimicrobial Agents and Chemotherapy|December 12, 2007
Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1Arunasalam Naguleswaran, Arsenio M Fialho, Anita Chaudhari, et al.Cell Cycle (Georgetown, Tex.)|July 25, 2006
Disrupting the entry barrier and attacking brain tumors: the role of the Neisseria H.8 epitope and the Laz proteinChang Soo Hong, Tohru Yamada, Wataru Hashimoto, et al.Leukemia Research|March 3, 2009
Bacterial proteins as potential drugs in the treatment of leukemiaJennifer M Kwan, Arsenio M Fialho, Madhuchanda Kundu, et al.Biochemical and Biophysical Research Communications|November 1, 2005
Human cytochrome c enters murine J774 cells and causes G1 and G2/M cell cycle arrest and induction of apoptosisYoshinori Hiraoka, Ana Teresa Granja, Arsenio M Fialho, et al.International Journal of Molecular Sciences|December 7, 2018
Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted TherapiesNuno Bernardes, Arsenio M FialhoBioengineered Bugs|February 18, 2011
Bioengineered bugs, drugs and contentious issues in patentingAnanda M ChakrabartyAdvances in Experimental Medicine and Biology|March 6, 2014
Microbial pathogenicity: a new approach to drug developmentAnanda M ChakrabartyPlos One|August 1, 2012
A BCAM0223 mutant of Burkholderia cenocepacia is deficient in hemagglutination, serum resistance, adhesion to epithelial cells and virulenceDalila Mil-Homens, Arsenio M FialhoBiochemistry|January 26, 2007
Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growthAnita Chaudhari, Magdy Mahfouz, Arsenio M Fialho, et al.Pageof 6